RYBOX Holdings — Biotechnology Fund
All 74 reported holdings of Biotechnology Fund (RYBOX) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Abbvie, Inc. | 8.17% | $11.18M |
| Amgen, Inc. | 5.05% | $6.90M |
| Gilead Sciences, Inc. | 4.49% | $6.15M |
| Vertex Pharmaceuticals, Inc. | 4.32% | $5.91M |
| Regeneron Pharmaceuticals, Inc. | 2.93% | $4.01M |
| Revolution Medicines, Inc. | 2.48% | $3.39M |
| Alnylam Pharmaceuticals, Inc. | 2.36% | $3.23M |
| Beone Medicines Ltd. | 2.17% | $2.97M |
| Moderna, Inc. | 2.15% | $2.94M |
| Biogen, Inc. | 2.13% | $2.91M |
| Natera, Inc. | 2.12% | $2.90M |
| Royalty Pharma PLC | 2.01% | $2.75M |
| Illumina, Inc. | 1.94% | $2.65M |
| Insmed, Inc. | 1.79% | $2.45M |
| United Therapeutics Corp. | 1.72% | $2.36M |
| Guardant Health, Inc. | 1.72% | $2.35M |
| Roivant Sciences Ltd. | 1.66% | $2.27M |
| Incyte Corp. | 1.62% | $2.21M |
| Viatris, Inc. | 1.55% | $2.12M |
| Neurocrine Biosciences, Inc. | 1.52% | $2.08M |
| Argenx SE | 1.48% | $2.02M |
| Jazz Pharmaceuticals PLC | 1.42% | $1.94M |
| Bridgebio Pharma, Inc. | 1.38% | $1.89M |
| Ionis Pharmaceuticals, Inc. | 1.35% | $1.85M |
| Cytokinetics, Inc. | 1.35% | $1.85M |
| Exelixis, Inc. | 1.33% | $1.82M |
| Alkermes PLC | 1.31% | $1.80M |
| Arrowhead Pharmaceuticals, Inc. | 1.25% | $1.71M |
| Biomarin Pharmaceutical, Inc. | 1.24% | $1.70M |
| Astrazeneca PLC | 1.23% | $1.68M |
| Halozyme Therapeutics, Inc. | 1.17% | $1.60M |
| Biontech SE | 1.16% | $1.59M |
| Crispr Therapeutics AG | 1.16% | $1.58M |
| Vaxcyte, Inc. | 1.16% | $1.58M |
| Tg Therapeutics, Inc. | 1.08% | $1.48M |
| Medpace Holdings, Inc. | 1.03% | $1.41M |
| Apogee Therapeutics, Inc. | 1.02% | $1.40M |
| Cogent Biosciences, Inc. | 1.00% | $1.37M |
| Twist Bioscience Corp. | 0.98% | $1.35M |
| Ptc Therapeutics, Inc. | 0.98% | $1.35M |
| Scholar Rock Holding Corp. | 0.98% | $1.35M |
| Nuvalent, Inc. | 0.98% | $1.35M |
| Axsome Therapeutics, Inc. | 0.96% | $1.31M |
| Cg Oncology, Inc. | 0.96% | $1.31M |
| Krystal Biotech, Inc. | 0.93% | $1.27M |
| Viking Therapeutics, Inc. | 0.90% | $1.23M |
| Travere Therapeutics, Inc. | 0.90% | $1.23M |
| Protagonist Therapeutics, Inc. | 0.89% | $1.21M |
| Ascendis Pharma A/s | 0.89% | $1.21M |
| Veracyte, Inc. | 0.88% | $1.20M |
| Liquidia Corp. | 0.86% | $1.18M |
| Kymera Therapeutics, Inc. | 0.83% | $1.14M |
| Madrigal Pharmaceuticals, Inc. | 0.79% | $1.09M |
| Ultragenyx Pharmaceutical, Inc. | 0.77% | $1.05M |
| Beam Therapeutics, Inc. | 0.74% | $1.02M |
| Immunitybio, Inc. | 0.74% | $1.01M |
| Mirum Pharmaceuticals, Inc. | 0.74% | $1.01M |
| Praxis Precision Medicines, Inc. | 0.72% | $988.63K |
| Rhythm Pharmaceuticals, Inc. | 0.71% | $978.06K |
| Acadia Pharmaceuticals, Inc. | 0.71% | $975.21K |
| Intellia Therapeutics, Inc. | 0.65% | $887.69K |
| Arcutis Biotherapeutics, Inc. | 0.63% | $859.99K |
| Dreyfus Treasury Obligations Cash Management | 0.59% | $810.75K |
| Recursion Pharmaceuticals, Inc. | 0.55% | $748.63K |
| Sarepta Therapeutics, Inc. | 0.54% | $742.65K |
| Summit Therapeutics, Inc. | 0.53% | $727.28K |
| Legend Biotech Corp. | 0.50% | $688.59K |
| Adma Biologics, Inc. | 0.50% | $688.21K |
| Celcuity, Inc. | 0.45% | $619.14K |
| Grail, Inc. | 0.38% | $521.10K |
| J.p. Morgan Securities LLC | 0.30% | $407.61K |
| Merrill Lynch, Pierce, Fenner & Smith Incorporated | 0.30% | $407.59K |
| Akero Therapeutics Inc | 0.00% | $2 |
| Sanofi SA - Cvr | 0.00% | $1 |
RYBOX overview: performance, fees, allocation and SEC filings